Literature DB >> 34582782

Viral recombination systems limit CRISPR-Cas targeting through the generation of escape mutations.

Amer A Hossain1, Jon McGinn1, Alexander J Meeske1, Joshua W Modell2, Luciano A Marraffini3.   

Abstract

CRISPR-Cas systems provide immunity to bacteria by programing Cas nucleases with RNA guides that recognize and cleave infecting viral genomes. Bacteria and their viruses each encode recombination systems that could repair the cleaved viral DNA. However, it is unknown whether and how these systems can affect CRISPR immunity. Bacteriophage λ uses the Red system (gam-exo-bet) to promote recombination between related phages. Here, we show that λ Red also mediates evasion of CRISPR-Cas targeting. Gam inhibits the host E. coli RecBCD recombination system, allowing recombination and repair of the cleaved DNA by phage Exo-Beta, which promotes the generation of mutations within the CRISPR target sequence. Red recombination is strikingly more efficient than the host's RecBCD-RecA in the production of large numbers of phages that escape CRISPR targeting. These results reveal a role for Red-like systems in the protection of bacteriophages against sequence-specific nucleases, which may facilitate their spread across viral genomes.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR; Cas9; Lambda; Red; recombination

Mesh:

Substances:

Year:  2021        PMID: 34582782      PMCID: PMC8516739          DOI: 10.1016/j.chom.2021.09.001

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   31.316


  79 in total

1.  A rapid method for efficient gene replacement in the filamentous fungus Aspergillus nidulans.

Authors:  M K Chaveroche; J M Ghigo; C d'Enfert
Journal:  Nucleic Acids Res       Date:  2000-11-15       Impact factor: 16.971

2.  Lambda red recombineering in Escherichia coli occurs through a fully single-stranded intermediate.

Authors:  J A Mosberg; M J Lajoie; G M Church
Journal:  Genetics       Date:  2010-09-02       Impact factor: 4.562

3.  Recombination-deficient deletions in bacteriophage lambda and their interaction with chi mutations.

Authors:  D Henderson; J Weil
Journal:  Genetics       Date:  1975-02       Impact factor: 4.562

4.  Phage response to CRISPR-encoded resistance in Streptococcus thermophilus.

Authors:  Hélène Deveau; Rodolphe Barrangou; Josiane E Garneau; Jessica Labonté; Christophe Fremaux; Patrick Boyaval; Dennis A Romero; Philippe Horvath; Sylvain Moineau
Journal:  J Bacteriol       Date:  2007-12-07       Impact factor: 3.490

5.  In vitro reconstitution of an Escherichia coli RNA-guided immune system reveals unidirectional, ATP-dependent degradation of DNA target.

Authors:  Sabin Mulepati; Scott Bailey
Journal:  J Biol Chem       Date:  2013-06-11       Impact factor: 5.157

6.  The diversity-generating benefits of a prokaryotic adaptive immune system.

Authors:  Stineke van Houte; Alice K E Ekroth; Jenny M Broniewski; Hélène Chabas; Ben Ashby; Joseph Bondy-Denomy; Sylvain Gandon; Mike Boots; Steve Paterson; Angus Buckling; Edze R Westra
Journal:  Nature       Date:  2016-04-13       Impact factor: 49.962

7.  CRISPR-Cas systems exploit viral DNA injection to establish and maintain adaptive immunity.

Authors:  Joshua W Modell; Wenyan Jiang; Luciano A Marraffini
Journal:  Nature       Date:  2017-03-29       Impact factor: 49.962

8.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

9.  RNA-programmed genome editing in human cells.

Authors:  Martin Jinek; Alexandra East; Aaron Cheng; Steven Lin; Enbo Ma; Jennifer Doudna
Journal:  Elife       Date:  2013-01-29       Impact factor: 8.140

10.  Manipulating or superseding host recombination functions: a dilemma that shapes phage evolvability.

Authors:  Louis-Marie Bobay; Marie Touchon; Eduardo P C Rocha
Journal:  PLoS Genet       Date:  2013-09-26       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.